Endothelial Cell Dysfunction: a Major Player in SARS-CoV-2 Infection (COVID-19)?

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2020 Jun 20

PMID 32554538

Citations 190

Authors

Alice Huertas

David Montani

Laurent Savale

Jeremie Pichon

Ly Tu

Florence Parent

Christophe Guignabert

Marc Humbert

Affiliations

Soon will be listed here.

Citing Articles

Risk factors for all-cause mortality during the COVID-19 pandemic compared with the pre-pandemic period in an adult population of Arkhangelsk, Russia.

Krieger E, Kudryavtsev A, Sharashova E, Samodova O, Postoev V Sci Rep. 2025; 15(1):1050.

PMID: 39774287 PMC: 11706959. DOI: 10.1038/s41598-025-85360-0.

GPR68 Mediates Lung Endothelial Dysfunction Caused by Bacterial Inflammation and Tissue Acidification.

Karki P, Ke Y, Zhang C, Promnares K, Li Y, Williams C Cells. 2025; 13(24.

PMID: 39768215 PMC: 11674861. DOI: 10.3390/cells13242125.

Immunity and Coagulation in COVID-19.

Avdonin P, Blinova M, Serkova A, Komleva L, Avdonin P Int J Mol Sci. 2024; 25(20).

PMID: 39457048 PMC: 11508857. DOI: 10.3390/ijms252011267.

Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook.

Kruger A, Joffe D, Lloyd-Jones G, Khan M, Salamon S, Laubscher G Semin Thromb Hemost. 2024; 51(3):256-271.

PMID: 39348850 PMC: 11906225. DOI: 10.1055/s-0044-1790603.

Evaluation of the relationship between and gene polymorphisms in COVID-19 patients with and without lung involvement.

Akcilar R, Kocak F, Kar F, Isiklar O, Atlanoglu S, Genc O Asian Biomed (Res Rev News). 2024; 18(4):157-170.

PMID: 39309472 PMC: 11414776. DOI: 10.2478/abm-2024-0022.

References

Engelmann B, Massberg S . Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2012; 13(1):34-45. DOI: 10.1038/nri3345. View

Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120-128. PMC: 7412750. DOI: 10.1056/NEJMoa2015432. View

Luther J, Gainer J, Murphey L, Yu C, Vaughan D, Morrow J . Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension. 2006; 48(6):1050-7. DOI: 10.1161/01.HYP.0000248135.97380.76. View

Connors J, Levy J . COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23):2033-2040. PMC: 7273827. DOI: 10.1182/blood.2020006000. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N . A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000; 87(5):E1-9. DOI: 10.1161/01.res.87.5.e1. View

Abouhashem A, Singh K, Azzazy H, Sen C . Is Low Alveolar Type II Cell in the Lungs of Elderly Linked to the Observed Severity of COVID-19?. Antioxid Redox Signal. 2020; 33(2):59-65. PMC: 7307702. DOI: 10.1089/ars.2020.8111. View

Becker R . COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020; 50(1):54-67. PMC: 7225095. DOI: 10.1007/s11239-020-02134-3. View

Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L . Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56(1). PMC: 7236820. DOI: 10.1183/13993003.01365-2020. View

10.

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-147. PMC: 7146714. DOI: 10.1016/j.thromres.2020.04.013. View

11.

Sawalha A, Zhao M, Coit P, Lu Q . Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020; 215:108410. PMC: 7139239. DOI: 10.1016/j.clim.2020.108410. View

12.

Grillet F, Behr J, Calame P, Aubry S, Delabrousse E . Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography. Radiology. 2020; 296(3):E186-E188. PMC: 7233384. DOI: 10.1148/radiol.2020201544. View

13.

Dveksler G, Dieffenbach C, Cardellichio C, McCuaig K, Pensiero M, Jiang G . Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J Virol. 1993; 67(1):1-8. PMC: 237331. DOI: 10.1128/JVI.67.1.1-8.1993. View

14.

Dolhnikoff M, Duarte-Neto A, Monteiro R, Ferraz da Silva L, Oliveira E, Saldiva P . Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020; 18(6):1517-1519. PMC: 7262093. DOI: 10.1111/jth.14844. View

15.

Criel M, Falter M, Jaeken J, Van Kerrebroeck M, Lefere I, Meylaerts L . Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?. Eur Respir J. 2020; 56(1). PMC: 7236825. DOI: 10.1183/13993003.01201-2020. View

16.

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D . COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300. PMC: 7233352. DOI: 10.1164/rccm.202003-0817LE. View

17.

Chen Z, Mi L, Xu J, Yu J, Wang X, Jiang J . Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis. 2005; 191(5):755-60. PMC: 7110046. DOI: 10.1086/427811. View

18.

Harzallah I, Debliquis A, Drenou B . Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020; 18(8):2064-2065. PMC: 7264773. DOI: 10.1111/jth.14867. View

19.

Imai Y, Kuba K, Neely G, Yaghubian-Malhami R, Perkmann T, van Loo G . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2):235-49. PMC: 7112336. DOI: 10.1016/j.cell.2008.02.043. View

20.

Chen L, Li X, Chen M, Feng Y, Xiong C . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6):1097-1100. PMC: 7184507. DOI: 10.1093/cvr/cvaa078. View